Africardio is a scientific congress that brings together cardiologists from all continents, and in particular from Africa. It takes place every 2 years. Interrupted by the health crisis, Africardio was back in action this year, putting on the table for discussion the difficulties facing sub-Saharan Africa, in particular the resurgence of cardiovascular disease and the damage it causes. Indeed, according to the WHO, non-communicable diseases such as cancer and cardiovascular disease are increasingly becoming the main cause of death in sub-Saharan Africa, where they were responsible for 37% of mortality in 2019, compared with 24% in 2000, mainly due to weaknesses in the implementation of essential control measures, notably prevention, diagnosis and care.
To discuss these issues, 16 countries from Africa and Europe, together with partners from the pharmaceutical industry and the medical equipment sector, met for three days of plenary sessions, thematic sessions, workshops and 12 open communication sessions.
As a fully-fledged healthcare player in Africa and the rest of the world, Bayer, a partner to professionals in the improvement, management, care and quality of life of patients, was present at this congress to participate in the discussions and to propose its solutions, such as Xarelto Rivaroxaban, as you can see from the pictures below:
